Alnylam Pharmaceuticals

Medical Device Coordination Group, European Union, Vodafone, Deloitte, IMS Maxims, MRI, Alnylam Pharmaceuticals
Roundup: Alnylam launches symptom tracker app for rare disease, UK startup raises £1.2M for mental fitness platform and more briefs
By Tammy Lovell | 07:08 am | October 22, 2021
Also, new guidance published on classification of medical devices in the EU.